Enphasys has today been granted US patent for the Enabling Absorption Device. The ENA monitors digestion, dissolution/release and permeation in the same assay and correctly ranks in vivo performance of advanced drug formulations. The technology may replace animal experiments in drug formulation development, save cost and reduce time to market
